| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.91B | 35.48B | 36.95B | 35.24B | 31.10B | 32.19B |
| Gross Profit | 23.95B | 21.73B | 23.01B | 22.82B | 20.07B | 21.08B |
| EBITDA | -641.00M | 2.31B | -76.00M | -1.11B | 2.90B | -743.00M |
| Net Income | -1.89B | 530.00M | -1.47B | -2.17B | 748.00M | -1.81B |
Balance Sheet | ||||||
| Total Assets | 22.13B | 19.05B | 20.42B | 22.66B | 24.43B | 24.83B |
| Cash, Cash Equivalents and Short-Term Investments | 5.08B | 6.70B | 4.66B | 5.57B | 7.07B | 5.32B |
| Total Debt | 6.30B | 5.38B | 6.24B | 6.24B | 6.94B | 7.15B |
| Total Liabilities | 15.08B | 11.74B | 13.66B | 14.44B | 14.04B | 14.30B |
| Stockholders Equity | 7.05B | 7.30B | 6.76B | 8.22B | 10.38B | 10.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.56B | -1.01B | -1.29B | 1.38B | -1.34B |
| Operating Cash Flow | 0.00 | -782.00M | 944.00M | 1.19B | 1.53B | -1.26B |
| Investing Cash Flow | 0.00 | 3.75B | -1.86B | -1.74B | 884.00M | 116.00M |
| Financing Cash Flow | 0.00 | -914.00M | 1.00M | -949.00M | -666.00M | 826.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥132.28B | 20.09 | ― | 0.70% | 5.15% | 47.13% | |
63 Neutral | ¥777.15B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
63 Neutral | ¥138.01B | 22.64 | ― | 1.88% | 16.70% | -0.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥1.49T | 28.68 | 15.36% | 0.78% | 11.29% | -4.88% | |
53 Neutral | ¥211.33B | 72.52 | ― | 0.69% | 10.75% | -14.28% | |
41 Neutral | ¥119.91B | -79.00 | ― | ― | -12.01% | ― |